|
Price and Volume
Detailed Quote
Compare to:
|
Top News
More News
Aveo Oncology (Nasdaq:AVEO) remained quiet Friday after the news that its partner to commercialize its potential drug for kidney cancer is giving up plans to seek approval for the drug in Europe, and... Read More
from Business Journals
|